Pricing Log in Create free account

Cogent Biosciences, Inc. (COGT) vs CRISPR Therapeutics AG (CRSP)

Cogent Biosciences, Inc. and CRISPR Therapeutics AG are both Biotechnology companies. Cogent Biosciences, Inc. and CRISPR Therapeutics AG are of similar size ($5.1B and $5.0B). Cogent Biosciences, Inc. grew revenue faster over the last twelve months: 110.2% against −64.8%. Cogent Biosciences, Inc. has the higher net margin (0.00% vs −3,368.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Cogent Biosciences, Inc. leads on 10 and CRISPR Therapeutics AG on 7.

Valuation

Metric COGT CRSP Biotechnology median
P/E n/m n/m 8.50
P/S 217.97 355.30 9.71
P/B 10.79 2.72 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 193.41 222.52 9.21
Earnings yield (7.32%) (9.66%) (33.15%)
Free cash flow yield (6.13%) (7.80%) (25.50%)

Profitability

Metric COGT CRSP Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (3,989.99%) 0.00%
Net margin 0.00% (3,368.72%) 0.00%
Free cash flow margin 0.00% (2,772.74%) 0.00%
Return on equity (146.55%) (26.09%) (56.36%)
Return on assets (68.00%) (19.28%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COGT CRSP Biotechnology median
Revenue growth (TTM) 110.23% (64.80%) 6.02%
EPS growth (last fiscal year) (11.34%) (49.08%) 30.26%
Revenue growth, 5-year CAGR 21.39% 37.31% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COGT CRSP Biotechnology median
Debt to equity 0.42 0.34 0.00
Current ratio 13.57 17.85 4.72
Net debt to EBITDA 2.04 3.06 0.96

Dividend

Metric COGT CRSP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COGT CRSP Biotechnology median
Market cap 5.12b 4.98b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack